Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Julphar
Chinese Patent Office
McKesson
Federal Trade Commission
Fish and Richardson
Moodys
McKinsey
Accenture

Generated: January 18, 2018

DrugPatentWatch Database Preview

Estradiol valerate - Generic Drug Details

« Back to Dashboard

What are the generic sources for estradiol valerate and what is the scope of estradiol valerate freedom to operate?

Estradiol valerate
is the generic ingredient in four branded drugs marketed by Par Sterile Products, Luitpold, Sandoz Inc, Watson Labs, Watson Labs Inc, and Savage Labs, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are seventy-five drug master file entries for estradiol valerate. Two suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for estradiol valerate
Ingredient-typeEstradiol Congeners
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists
Tentative approvals for ESTRADIOL VALERATE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe1MG;2MG;2MGTABLET;ORAL
➤ Subscribe➤ Subscribe3MG;2MG;3MGTABLET;ORAL

US Patents and Regulatory Information for estradiol valerate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE estradiol valerate; testosterone enanthate INJECTABLE;INJECTION 085865-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE estradiol valerate; testosterone enanthate INJECTABLE;INJECTION 085860-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Sterile Products DELESTROGEN estradiol valerate INJECTABLE;INJECTION 009402-003 Approved Prior to Jan 1, 1982 AO RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 090920-001 Jan 19, 2010 AO RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Sterile Products DELESTROGEN estradiol valerate INJECTABLE;INJECTION 009402-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 040628-003 Oct 4, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 083546-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 083547-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Savage Labs DITATE-DS estradiol valerate; testosterone enanthate INJECTABLE;INJECTION 086423-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 040628-002 Oct 4, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Novartis
Moodys
AstraZeneca
Johnson and Johnson
Cerilliant
Accenture
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot